ES455791A1 - Improvement in organic compound - Google Patents

Improvement in organic compound

Info

Publication number
ES455791A1
ES455791A1 ES455791A ES455791A ES455791A1 ES 455791 A1 ES455791 A1 ES 455791A1 ES 455791 A ES455791 A ES 455791A ES 455791 A ES455791 A ES 455791A ES 455791 A1 ES455791 A1 ES 455791A1
Authority
ES
Spain
Prior art keywords
alkyl
tetrahydroequinocandin
cycloalkyl
improvement
organic compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES455791A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES455791A1 publication Critical patent/ES455791A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Abstract

Tetrahydroequinocandin-B derivs. of formula (I) and their salts with organic or mineral acids are new: R3CH2CH2(CH2)mNR gamma R2 (I). (R3 is the residue R5=(CH2)16CH3, m=0-4, R1=H, 1-12C alkyl, 3-7C cycloalkyl, 3-7C cycloalkyl -(1 -3C)alkyl, hydroxyethyl, 3-6C alkoxyethyl, furylmethyl, tetrahydrofurylmethyl, or phenyl or 7-10C phenalkyl in which the rings are opt. substd. by one or two F, Cl, Br, OH or 1-4C alkyl or alkoxy. R2=H or 1-4C alkyl, or R1 and R2 together are -(CH2)2.A.(CH2)2-. A=bond, CH2, O or NR4, R4=H or 1-4C alkyl). They are prepd. e.g. by reacting R3H with HO.CH2.CH2(CH2)m.NR1R2. (I) are antimycotics esp. active against Candida species pathogenic to humans, with little or no effect on bacteria. They are administered in usual oral, rectal, parental or topic formulations at daily doses of 10-500 mg. Specifically claimed is the 2-aminoethyl ether of tetrahydroequinocandin-B.
ES455791A 1976-02-12 1977-02-10 Improvement in organic compound Expired ES455791A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH170676 1976-02-12
CH340376 1976-03-18
CH1446876 1976-11-17

Publications (1)

Publication Number Publication Date
ES455791A1 true ES455791A1 (en) 1978-11-01

Family

ID=27173191

Family Applications (1)

Application Number Title Priority Date Filing Date
ES455791A Expired ES455791A1 (en) 1976-02-12 1977-02-10 Improvement in organic compound

Country Status (11)

Country Link
JP (1) JPS52116496A (en)
AU (1) AU2222977A (en)
DE (1) DE2704030A1 (en)
DK (1) DK46577A (en)
ES (1) ES455791A1 (en)
FI (1) FI770377A (en)
FR (1) FR2340947A1 (en)
IL (1) IL51426A0 (en)
NL (1) NL7701295A (en)
PT (1) PT66186B (en)
SE (1) SE7701155L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742435A1 (en) * 1976-09-28 1978-04-06 Sandoz Ag AMINO ALKYL ETHER OF THE PEPTIDES TETRAHYDRO- SL 7810 / F-II, S 31794 / F-1, ACULEACIN A AND TETRAHYDROECHINOCANDIN B, THEIR USE AND PRODUCTION
FR2458551A1 (en) * 1979-06-08 1981-01-02 Lilly Co Eli NOVEL ANTIBIOTICS, THEIR PREPARATION AND THEIR USE
CA1170598A (en) * 1979-12-13 1984-07-10 Bernard J. Abbott Process for the preparation of cyclic peptide nuclei
FR2476074A1 (en) * 1979-12-13 1981-08-21 Lilly Co Eli Acylated amino poly:cyclic peptide antibiotics - useful for controlling fungal infections
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
JPH0276880A (en) * 1988-06-16 1990-03-16 Sankyo Co Ltd Cachexia-improving remidy
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5552521A (en) * 1995-02-10 1996-09-03 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
CN114616238A (en) * 2019-12-06 2022-06-10 上海森辉医药有限公司 Echinocandin analogue and preparation method thereof

Also Published As

Publication number Publication date
PT66186B (en) 1978-10-13
NL7701295A (en) 1977-08-16
PT66186A (en) 1977-03-01
DK46577A (en) 1977-08-13
SE7701155L (en) 1977-08-13
IL51426A0 (en) 1977-04-29
AU2222977A (en) 1978-08-17
JPS52116496A (en) 1977-09-29
FI770377A (en) 1977-08-13
DE2704030A1 (en) 1977-08-18
FR2340947A1 (en) 1977-09-09

Similar Documents

Publication Publication Date Title
SE8304465D0 (en) PROCEDURE FOR MANUFACTURING CEFEM SOCIETIES
ES8304072A1 (en) preparation, compositions and intermediates.
ES455791A1 (en) Improvement in organic compound
DE3775319D1 (en) IMIDAZOLYLGUANIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
ES8403910A1 (en) 3.6-dianhydro-hexite nitrates, processes for their preparation and pharmaceutical compositions.
ES8705396A1 (en) Substituted imidazoles.
BR9504456A (en) Compounds and process for their preparation their use and medicine and process for their preparation
KR927003537A (en) 4,5-cycloalkano-3-benzeazin-7-ol derivatives and uses thereof
ES434976A1 (en) Antibiotic pharmaceutical compositions
ES388881A1 (en) 1-(2'-cyano-phenoxy)-2-hydroxy-3-ethylamino-propane and salts thereof
ES8205227A1 (en) starting compounds and process for their preparation.
ES455940A1 (en) 2,9-Dioxatricyclo{8 4,3,1,0{hu 3,7{b {9 {0 decane derivatives and pharmaceutical compositions thereof
ES8607973A1 (en) Amino-lower-alkyl-penem derivatives, process for their preparation, pharmaceutical compositions containing them and their use.
ES464729A1 (en) Benzisothiazolon process for preparing same and medical composition containing same
ES8205804A1 (en) Benzopyrano (2,3-d) triazole-derivatives, their preparation and use in pharmaceutical compositions.
ES394968A1 (en) 5-(2-amino-alkoxy-phenoxy-methyl)-3-alkyl-isoxazoles - useful as hypotensives and sedatives
FR2356652A1 (en) NEW PENICILLINS AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
ES8603846A1 (en) Aminoethoxybenzylalcohol derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2241300A1 (en) Antidepressant N-carbamoyl-phenyl-acet- or propion-amidines - active by oral, rectal or parenteral administration
GB1094083A (en) Improvements in and relating to immunology
ES8604232A1 (en) Beta-lactam antibiotics.
FR2363560A1 (en) NEW COMPOUND WITH ANALGESIC ACTION AND THERAPEUTIC COMPOSITIONS IN CONTAINER
GB1279547A (en) N-arylidene derivatives of erythromycylamine
GB1395772A (en) 1-aryl-3h-1,4-benzodiazepin-2,5-1h,4h-diones
FR2248050A1 (en) 4,5-dihydro-4h-s-triazolo (4,3-a) (1,4) benzodiazepine - cns depressants, anti-convulsants, anti-aggressives and somatic reflex in